Achilles Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Achilles Therapeutics (ACHL) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Achilles Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Achilles Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Achilles Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $879 | 989 | 0.89 |
| 2023-09-30 | $899 | 989 | 0.91 |
| 2023-06-30 | $935 | 989 | 0.95 |
| 2023-03-31 | $999 | 989 | 1.01 |
| 2022-12-31 | $999 | 989 | 1.01 |
| 2022-06-30 | $4.0k | 1.6k | 2.56 |
| 2022-03-31 | $14k | 4.6k | 3.04 |
| 2021-12-31 | $17k | 3.4k | 4.95 |
| 2021-03-31 | $10M | 626k | 16.00 |